Corporate Governance25 Sept 2026, 05:30 pm
Pharmaids Pharmaceuticals Ltd: Trading Window Closed
AI Summary
Pharmaids Pharmaceuticals Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will remain shut from October 01, 2026, until 48 hours after the declaration of the company's unaudited financial results for the quarter and half-year ended September 30, 2026. The specific date for the board meeting to consider these results will be intimated later. The company will also update its website with this information.
Key Highlights
- Trading window closed for designated persons and immediate relatives.
- Closure effective from October 01, 2026.
- Period extends until 48 hours post Q2 FY27 results declaration.
- Compliance with SEBI Insider Trading Regulations is maintained.
- Board meeting date for results to be announced separately.
Price Impact
More from PHARMAID